Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study
Background: Since the roll-out of antiretroviral therapy (ART) in sub-Saharan Africa (sSA) in the early 2000s, the life expectancy of people infected with the human immunodeficiency virus (HIV) has increased. However, the gains made in reducing mortality from HIV-related complications have been miti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2019-08-01
|
| Series: | African Journal of Primary Health Care & Family Medicine |
| Subjects: | |
| Online Access: | https://phcfm.org/index.php/phcfm/article/view/1974 |
| _version_ | 1811282933087993856 |
|---|---|
| author | Rumbidzai Chireshe Keshena Naidoo Rudo Nyamakura |
| author_facet | Rumbidzai Chireshe Keshena Naidoo Rudo Nyamakura |
| author_sort | Rumbidzai Chireshe |
| collection | DOAJ |
| description | Background: Since the roll-out of antiretroviral therapy (ART) in sub-Saharan Africa (sSA) in the early 2000s, the life expectancy of people infected with the human immunodeficiency virus (HIV) has increased. However, the gains made in reducing mortality from HIV-related complications have been mitigated by the emergence of age-related chronic non-communicable diseases (NCDs), such as hypertension. Protease inhibitors (PIs), and prolonged exposure to highly active ART (HAART) have been implicated in the development of hypertension in HIV-positive people.
Aim: To investigate the prevalence of hypertension and its associated risk factors among HIV-positive patients receiving ART.
Setting: The study was carried out at an urban-based clinic that provides HAART and primary care to HIV-positive people in Harare, Zimbabwe.
Methods: A descriptive, cross-sectional study was conducted among non-pregnant adults on HAART attending the clinic between July and August 2018.
Results: We studied 600 HIV-positive adult patients, of which 56% were women. The prevalence rate of hypertension was 29.9%. Of the participants in the hypertensive group, 11.2% were not previously diagnosed or on treatment. Factors associated with hypertension were advanced age, use of HAART for longer than 10 years, being overweight, a family history of hypertension and smoking. There was a 68.8% prevalence of body mass index greater than 25 kg/m2 among all participants.
Conclusion: High hypertension prevalence was recorded. Hypertension was not associated with gender or use of PI regimens but being overweight was highly prevalent. Greater vigilance and integration of resources is required in the overall treatment and monitoring of HIV-positive patients for co-morbidities. |
| first_indexed | 2024-04-13T02:01:30Z |
| format | Article |
| id | doaj.art-434c7bfab17c426ebf614e272d259b93 |
| institution | Directory Open Access Journal |
| issn | 2071-2928 2071-2936 |
| language | English |
| last_indexed | 2024-04-13T02:01:30Z |
| publishDate | 2019-08-01 |
| publisher | AOSIS |
| record_format | Article |
| series | African Journal of Primary Health Care & Family Medicine |
| spelling | doaj.art-434c7bfab17c426ebf614e272d259b932022-12-22T03:07:36ZengAOSISAfrican Journal of Primary Health Care & Family Medicine2071-29282071-29362019-08-01111e1e810.4102/phcfm.v11i1.1974648Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive studyRumbidzai Chireshe0Keshena Naidoo1Rudo Nyamakura2Discipline of Nursing and Public Health, University of KwaZulu-Natal, DurbanSchool of Nursing, Public Health and Family Medicine, University of KwaZulu-Natal, DurbanDepartment of Nursing Science, College of Health Sciences, University of Zimbabwe, HarareBackground: Since the roll-out of antiretroviral therapy (ART) in sub-Saharan Africa (sSA) in the early 2000s, the life expectancy of people infected with the human immunodeficiency virus (HIV) has increased. However, the gains made in reducing mortality from HIV-related complications have been mitigated by the emergence of age-related chronic non-communicable diseases (NCDs), such as hypertension. Protease inhibitors (PIs), and prolonged exposure to highly active ART (HAART) have been implicated in the development of hypertension in HIV-positive people. Aim: To investigate the prevalence of hypertension and its associated risk factors among HIV-positive patients receiving ART. Setting: The study was carried out at an urban-based clinic that provides HAART and primary care to HIV-positive people in Harare, Zimbabwe. Methods: A descriptive, cross-sectional study was conducted among non-pregnant adults on HAART attending the clinic between July and August 2018. Results: We studied 600 HIV-positive adult patients, of which 56% were women. The prevalence rate of hypertension was 29.9%. Of the participants in the hypertensive group, 11.2% were not previously diagnosed or on treatment. Factors associated with hypertension were advanced age, use of HAART for longer than 10 years, being overweight, a family history of hypertension and smoking. There was a 68.8% prevalence of body mass index greater than 25 kg/m2 among all participants. Conclusion: High hypertension prevalence was recorded. Hypertension was not associated with gender or use of PI regimens but being overweight was highly prevalent. Greater vigilance and integration of resources is required in the overall treatment and monitoring of HIV-positive patients for co-morbidities.https://phcfm.org/index.php/phcfm/article/view/1974hypertension prevalenceHIV-positivehighly active antiretroviral therapysub-Saharan Africaprotease inhibitorsantiretroviral therapynon-communicable diseases |
| spellingShingle | Rumbidzai Chireshe Keshena Naidoo Rudo Nyamakura Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study African Journal of Primary Health Care & Family Medicine hypertension prevalence HIV-positive highly active antiretroviral therapy sub-Saharan Africa protease inhibitors antiretroviral therapy non-communicable diseases |
| title | Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study |
| title_full | Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study |
| title_fullStr | Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study |
| title_full_unstemmed | Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study |
| title_short | Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study |
| title_sort | hypertension among human immunodeficiency virus infected patients on treatment at parirenyatwa hospital a descriptive study |
| topic | hypertension prevalence HIV-positive highly active antiretroviral therapy sub-Saharan Africa protease inhibitors antiretroviral therapy non-communicable diseases |
| url | https://phcfm.org/index.php/phcfm/article/view/1974 |
| work_keys_str_mv | AT rumbidzaichireshe hypertensionamonghumanimmunodeficiencyvirusinfectedpatientsontreatmentatparirenyatwahospitaladescriptivestudy AT keshenanaidoo hypertensionamonghumanimmunodeficiencyvirusinfectedpatientsontreatmentatparirenyatwahospitaladescriptivestudy AT rudonyamakura hypertensionamonghumanimmunodeficiencyvirusinfectedpatientsontreatmentatparirenyatwahospitaladescriptivestudy |